Skip to main content
Premium Trial:

Request an Annual Quote

Translational Genomics in Autism Research Collaboration

NEW YORK, April 2 - The Translational Genomics Institute of Phoenix, Ariz., will enter into a research alliance with the Southwest Autism Research and Resource Center, according to news reports.


TGen was created to apply genomic discoveries into treatments for common diseases.


The Southwest Autism center will provide access to patients, families, and doctors for genetic testing and possible treatment, according to an article published today in The Arizona Republic newspaper.


The alliance is the first for Translational Genomics, a public-private collaboration with ties to the University of Arizona, Northern Arizona University and Arizona State University. It is part of an effort by Arizona academic administrators, politicians and business to attract biotechnology research to the state. Jeffrey Trent, former scientific director of the National Human Genome Research Institute, was named president and CEO in June.


TGen is funded with $90 million in public and private funds.

The Scan

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.

Tibetan Study Finds Adaptive Variant Influencing Skin Pigmentation

With a combination of phenotyping and genetic data, researchers document at PNAS a Tibetan-enriched enhancer variant influencing melanin synthesis and ultraviolet light response.

Domestication Linked to Nervous System Genes in Inbred Mouse Strains

Researchers highlighted more than 300 positively selected genes in domesticated mice, including genes linked to nervous system function or behavior in Genome Biology.

ALS Genetic Testing May Be Informative Across Age Ranges, Study Finds

Researchers in the journal Brain identified clinically actionable variants in a significant subset of older ALS patients, prompting them to point to the potential benefits of broader test use.